EFX CEO Files Form 144 to Sell 48,264 Shares Worth $11.9 M

Equifax Inc. (EFX) Form 144 filing: CEO Mark W. Begor has filed notice to sell up to 48,264 common shares through Fidelity Brokerage on or after 07/28/2025.

Rhea-AI Filing Summary

Equifax Inc. (EFX) Form 144 filing: CEO Mark W. Begor has filed notice to sell up to 48,264 common shares through Fidelity Brokerage on or after 07/28/2025. At the last reported market price, the proposed sale is valued at $11.85 million. The filing lists 123,797,380 shares outstanding, so the planned disposition equals roughly 0.04 % of total shares.

The shares come from two prior equity awards:

• 20,304 shares vested as restricted stock on 05/04/2021 (non-cash compensation).
• 27,960 shares from options granted 02/21/2020 and exercised for cash on 07/28/2025.

Rule 144 also discloses that Begor previously sold 22,160 shares on 04/28/2025 for $5.69 million.

No additional financial metrics, earnings data, or company guidance are included in this short-form notice; the document solely satisfies SEC requirements for advance disclosure of certain insider sales.

Insights

Financial Analyst

TL;DR: CEO plans to sell ≈48k shares (~$11.9 M); small vs. float—neutral but worth monitoring after earlier Q2 sales.

The filing signals another scheduled insider transaction by Mark Begor. Combined with April’s 22,160-share sale, the CEO will have disposed of about 70,000 shares in three months, but that still represents under 0.1 % of EFX’s 124 million shares outstanding. Rule 144 compliance suggests an orderly sale via brokerage, limiting market disruption. Because the divestiture is modest relative to float and no adverse operational information is disclosed, the near-term valuation impact should be minimal. Nevertheless, repeated insider sales can influence sentiment, so investors may watch subsequent ownership updates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Equifax (EFX) shares does the CEO plan to sell?

The Form 144 covers 48,264 common shares.

What is the estimated market value of the proposed sale?

The aggregate value listed is $11,850,742.56.

When can the shares be sold under this Form 144?

The filing lists an approximate sale date of 07/28/2025 on the NYSE.

Were there recent insider sales before this notice?

Yes. Mark W. Begor sold 22,160 shares on 04/28/2025 for $5.69 million.

What portion of Equifax's outstanding shares does the planned sale represent?

About 0.04 % of the 123,797,380 shares outstanding.

Which broker will execute the transaction?

The shares are to be sold through Fidelity Brokerage Services LLC, Smithfield, RI.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/28/2025 - 11:05 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001335111
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EQUIFAX INC
SEC File Number	001-06605
Address of Issuer	1550 PEACHTREE ST NW ATLANTA GEORGIA 30302
Phone	4048858000
Name of Person for Whose Account the Securities are To Be Sold	Begor Mark W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	48264	11850742.56	123797380	07/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2021	Restricted Stock Vesting	Issuer			20304	05/04/2021	Compensation
Common	07/28/2025	Option Granted - 02/21/2020	Issuer			27960	07/28/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark W. Begor 1550 Peachtree Street N.W. Atlanta GA 30309	Common	04/28/2025	22160	5686477.60

144: Remarks and Signature

Remarks
Date of Notice	07/28/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/14/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jackson Harris, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark W. Begor
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)